MedTrace Logo

Effect of Ginseol Kg1 on Blood Pressure Lowering

NCT01483430 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2011-12-02

No results posted yet for this study

Summary

In this study, we investigate the effects of Ginseol Kg1 (Korea red ginseng extract) on blood pressure in prehypertensive or stage I hypertensive patients.

Conditions

  • Prehypertension
  • Hypertension, Stage I

Interventions

DRUG

Ginseol Kg1 (low dose)

1 capsule/day (100mg of Ginseol Kg1), Duration: 8 weeks

DRUG

Ginseol Kg1(high dose)

1 capsule/day (300mg of Ginseol Kg1), Duration: 8 weeks

DRUG

Placebo

1 capsule/day (starch), Duration: 8 weeks

Sponsors & Collaborators

  • DongGuk University

    collaborator OTHER

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Kwang-il Kim, MD, PhD · Seoul National University Bundang Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2012-06-30
Completion
2012-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01483430 on ClinicalTrials.gov